Interindividual variation in the proteome of human peripheral blood mononuclear cells
- PMID: 23613975
- PMCID: PMC3629925
- DOI: 10.1371/journal.pone.0061933
Interindividual variation in the proteome of human peripheral blood mononuclear cells
Abstract
Peripheral blood mononuclear cells (PBMCs) are main actors in inflammatory processes and linked to many diseases, including rheumatoid arthritis, atherosclerosis, asthma, HIV and cancer. Moreover, they seem an interesting 'surrogate tissue' that can be used in biomarker discovery. In order to get a good experimental design for quantitative expression studies, the knowledge of the interindividual variation is an essential part. Therefore, PBMCs were isolated from 24 healthy volunteers (15 males, 9 females, ages 63-86) with no clinical signs of inflammation. The extracted proteins were separated using the two dimensional difference in gel electrophoresis technology (2D-DIGE), and the gel images were processed with the DeCyder 2D software. Protein spots present in at least 22 out of 24 healthy volunteers were selected for further statistical analysis. Determination of the coefficient of variation (CV) of the normalized spot volume values of these proteins, reveals that the total variation of the PBMC proteome varies between 12,99% to 148,45%, with a mean value of 28%. A supplemental look at the causes of technical variation showed that the isolation of PBMCs from whole blood is the factor which influences the experimental variance the most. This isolation should be handled with extra care and an additional washing step would be beneficial. Knowing the extent of variation, we show that at least 10 independent samples per group are needed to obtain statistical powerful data. This study demonstrates the importance of considering variance of a human population for a good experimental design for future protein profiling or biomarker studies.
Conflict of interest statement
Figures




References
-
- Anderson NL (2010) The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin Chem 56: 177–185 clinchem.2009.126706 [pii];10.1373/clinchem.2009.126706 [doi]. - PubMed
-
- Hu J, Coombes KR, Morris JS, Baggerly KA (2005) The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales. Brief Funct Genomic Proteomic 3: 322–331. - PubMed
-
- Levin Y (2011) The role of statistical power analysis in quantitative proteomics. Proteomics 11: 2565–2567 10.1002/pmic.201100033 [doi]. - DOI - PubMed
-
- Hunt SM, Thomas MR, Sebastian LT, Pedersen SK, Harcourt RL, et al. (2005) Optimal replication and the importance of experimental design for gel-based quantitative proteomics. J Proteome Res 4: 809–819 10.1021/pr049758y [doi]. - DOI - PubMed
-
- Molloy MP, Brzezinski EE, Hang J, McDowell MT, VanBogelen RA (2003) Overcoming technical variation and biological variation in quantitative proteomics. Proteomics 3: 1912–1919 10.1002/pmic.200300534 [doi]. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources